BRNS: Barinthus Biotherapeutics Plc Financial Statements
Balance sheet, income statement, and cash flow statements for Barinthus Biotherapeutics Plc (BRNS).
$48.60M Market Cap.
BRNS Market Cap. (MRY)
BRNS Shares Outstanding (MRY)
BRNS Assets (MRY)
Total Assets
$160.33M
Total Liabilities
$30.19M
Total Investments
$0
BRNS Income (MRY)
Revenue
$14.97M
Net Income
-$61.07M
Operating Expense
$82.94M
BRNS Cash Flow (MRY)
CF Operations
-$28.94M
CF Investing
-$892.00K
CF Financing
$2.16M
BRNS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $160,327,000 (-25.26%) | $214,506,000 (-20.61%) | $270,205,000 (-3.74%) | $280,715,000 (454.05%) |
Assets Current | $125,742,000 (-19.86%) | $156,905,000 (-26.35%) | $213,041,000 (-6.05%) | $226,765,000 (373.40%) |
Assets Non-Current | $34,585,000 (-39.96%) | $57,601,000 (0.76%) | $57,164,000 (5.96%) | $53,950,000 (1851.18%) |
Goodwill & Intangible Assets | $21,947,000 (-41.19%) | $37,317,000 (-7.81%) | $40,478,000 (-8.13%) | $44,060,000 (0%) |
Shareholders Equity | $130,029,000 (-30.39%) | $186,784,000 (-23.10%) | $242,896,000 (-3.66%) | $252,125,000 (783.04%) |
Property Plant & Equipment Net | $11,757,000 (-39.40%) | $19,402,000 (23.50%) | $15,710,000 (72.90%) | $9,086,000 (228.61%) |
Cash & Equivalents | $112,400,000 (-20.90%) | $142,090,000 (-26.90%) | $194,385,000 (-9.19%) | $214,054,000 (394.74%) |
Accumulated Other Comprehensive Income | -$25,868,000 (-10.95%) | -$23,315,000 (30.32%) | -$33,460,000 (-294.20%) | -$8,488,000 (-582.86%) |
Deferred Revenue | $1,738,000 (0%) | $0 (0%) | $0 (0%) | $182,000 (-25.71%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $5,847,000 (29135.00%) | $20,000 (-96.14%) |
Trade & Non-Trade Payables | $2,474,000 (54.53%) | $1,601,000 (-57.28%) | $3,748,000 (54.94%) | $2,419,000 (-48.17%) |
Accumulated Retained Earnings (Deficit) | -$237,664,000 (-34.59%) | -$176,590,000 (-71.04%) | -$103,243,000 (4.92%) | -$108,585,000 (-88.12%) |
Tax Assets | $7,139,000 (45.46%) | $4,908,000 (8.08%) | $4,541,000 (-27.10%) | $6,229,000 (130.02%) |
Tax Liabilities | $438,000 (-23.69%) | $574,000 (-84.68%) | $3,746,000 (-53.66%) | $8,084,000 (0%) |
Total Debt | $12,007,000 (-7.47%) | $12,976,000 (47.91%) | $8,773,000 (21.48%) | $7,222,000 (-84.42%) |
Debt Current | $1,920,000 (7.56%) | $1,785,000 (312.24%) | $433,000 (-36.51%) | $682,000 (255.21%) |
Debt Non-Current | $10,087,000 (-9.87%) | $11,191,000 (34.18%) | $8,340,000 (27.52%) | $6,540,000 (-85.84%) |
Total Liabilities | $30,192,000 (9.75%) | $27,511,000 (1.88%) | $27,004,000 (-4.08%) | $28,153,000 (-47.68%) |
Liabilities Current | $15,657,000 (24.28%) | $12,598,000 (2.91%) | $12,242,000 (9.72%) | $11,158,000 (46.03%) |
Liabilities Non-Current | $14,535,000 (-2.53%) | $14,913,000 (1.02%) | $14,762,000 (-13.14%) | $16,995,000 (-63.19%) |
BRNS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $14,969,000 (1766.46%) | $802,000 (-98.21%) | $44,703,000 (16580.22%) | $268,000 (-94.44%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $29,670,000 (-25.53%) | $39,842,000 (523.12%) | $6,394,000 (-74.54%) | $25,118,000 (139.68%) |
Research & Development Expense | $42,236,000 (-5.88%) | $44,874,000 (5.96%) | $42,350,000 (107.89%) | $20,371,000 (41.59%) |
Operating Expenses | $82,939,000 (-2.10%) | $84,716,000 (73.80%) | $48,744,000 (7.16%) | $45,489,000 (82.93%) |
Interest Expense | $53,000 (89.29%) | $28,000 (47.37%) | $19,000 (-99.29%) | $2,668,000 (-25.89%) |
Income Tax Expense | -$44,000 (98.57%) | -$3,075,000 (31.22%) | -$4,471,000 (-15867.86%) | -$28,000 (-129.47%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$61,183,000 (16.70%) | -$73,447,000 (-1480.32%) | $5,321,000 (110.41%) | -$51,112,000 (-185.02%) |
Net Income to Non-Controlling Interests | -$109,000 (-9.00%) | -$100,000 (-376.19%) | -$21,000 (91.50%) | -$247,000 (-8.81%) |
Net Income | -$61,074,000 (16.73%) | -$73,347,000 (-1473.03%) | $5,342,000 (110.50%) | -$50,865,000 (-187.28%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$61,074,000 (16.73%) | -$73,347,000 (-1473.03%) | $5,342,000 (110.50%) | -$50,865,000 (-187.28%) |
Weighted Average Shares | $39,348,240 (2.51%) | $38,386,491 (3.06%) | $37,248,126 (43.85%) | $25,894,375 (227.59%) |
Weighted Average Shares Diluted | $39,348,240 (2.51%) | $38,386,491 (0.57%) | $38,169,307 (47.40%) | $25,894,375 (227.59%) |
Earning Before Interest & Taxes (EBIT) | -$61,065,000 (20.07%) | -$76,394,000 (-8683.60%) | $890,000 (101.85%) | -$48,225,000 (-244.19%) |
Gross Profit | $14,969,000 (1766.46%) | $802,000 (-98.21%) | $44,703,000 (16580.22%) | $268,000 (-94.44%) |
Operating Income | -$67,970,000 (19.00%) | -$83,914,000 (-1976.57%) | -$4,041,000 (91.06%) | -$45,221,000 (-125.59%) |
BRNS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$892,000 (83.52%) | -$5,413,000 (5.86%) | -$5,750,000 (55.47%) | -$12,912,000 (-4306.83%) |
Net Cash Flow from Financing | $2,163,000 (15.54%) | $1,872,000 (476.00%) | $325,000 (-99.85%) | $222,742,000 (437.57%) |
Net Cash Flow from Operations | -$28,940,000 (43.17%) | -$50,925,000 (-252.89%) | -$14,431,000 (55.71%) | -$32,583,000 (-195.46%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$29,690,000 (43.23%) | -$52,295,000 (-165.88%) | -$19,669,000 (-111.52%) | $170,788,000 (436.50%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | -$11,766,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$892,000 (83.52%) | -$5,413,000 (5.86%) | -$5,750,000 (-401.75%) | -$1,146,000 (-291.13%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | -$159,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $2,163,000 (6.29%) | $2,035,000 (320.45%) | $484,000 (-99.79%) | $225,848,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$2,021,000 (-193.09%) | $2,171,000 (1060.96%) | $187,000 (102.90%) | -$6,459,000 (-475.52%) |
Share Based Compensation | $4,709,000 (-6.84%) | $5,055,000 (-48.82%) | $9,877,000 (-40.09%) | $16,487,000 (354.81%) |
Depreciation Amortization & Accretion | $7,243,000 (7.19%) | $6,757,000 (21.99%) | $5,539,000 (489.26%) | $940,000 (351.92%) |
BRNS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -408.00% (95.54%) | -9145.50% (-76952.94%) | 11.90% (100.06%) | -18979.50% (-5067.30%) |
EBITDA Margin | -359.60% (95.86%) | -8682.90% (-60397.92%) | 14.40% (100.08%) | -17643.70% (-6062.66%) |
Return on Average Equity (ROAE) | -44.50% (-13.23%) | -39.30% (-1971.43%) | 2.10% (107.14%) | -29.40% (-149.25%) |
Return on Average Assets (ROAA) | -36.50% (-6.73%) | -34.20% (-1900.00%) | 1.90% (109.00%) | -21.10% (58.46%) |
Return on Sales (ROS) | -407.90% (95.72%) | -9525.40% (-476370.00%) | 2.00% (100.01%) | -17994.40% (-6092.15%) |
Return on Invested Capital (ROIC) | -217.60% (-1.07%) | -215.30% (-8380.77%) | 2.60% (100.75%) | -344.70% (-512.26%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.78 (59.68%) | -1.93 (-111.51%) | 16.79 (396.15%) | -5.67 |
Price to Sales Ratio (P/S) | 3.17 (-98.20%) | 176.62 (8920.22%) | 1.96 (-99.82%) | 1,073.46 |
Price to Book Ratio (P/B) | 0.37 (-50.92%) | 0.76 (111.08%) | 0.36 (-76.50%) | 1.54 |
Debt to Equity Ratio (D/E) | 0.23 (57.82%) | 0.15 (32.43%) | 0.11 (-0.89%) | 0.11 (107.68%) |
Earnings Per Share (EPS) | -1.55 (18.85%) | -1.91 (-1464.29%) | 0.14 (107.14%) | -1.96 (12.50%) |
Sales Per Share (SPS) | 0.38 (1709.52%) | 0.02 (-98.25%) | 1.2 (11900.00%) | 0.01 (-98.36%) |
Free Cash Flow Per Share (FCFPS) | -0.76 (48.37%) | -1.47 (-170.85%) | -0.54 (58.40%) | -1.3 (9.01%) |
Book Value Per Share (BVPS) | 3.31 (-32.08%) | 4.87 (-25.38%) | 6.52 (-33.03%) | 9.74 (308.50%) |
Tangible Assets Book Value Per Share (TABVPS) | 3.52 (-23.81%) | 4.62 (-25.15%) | 6.17 (-32.52%) | 9.14 (42.57%) |
Enterprise Value Over EBIT (EV/EBIT) | 1 (0%) | 0 (0%) | -117 (-3800.00%) | -3 |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.83 (996.05%) | 0.08 (100.47%) | -16.21 (-374.47%) | -3.42 |
Asset Turnover | 0.09 (2125.00%) | 0 (-97.50%) | 0.16 (15900.00%) | 0 (-99.28%) |
Current Ratio | 8.03 (-35.52%) | 12.46 (-28.43%) | 17.4 (-14.37%) | 20.32 (224.18%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$29,832,000 (47.05%) | -$56,338,000 (-179.16%) | -$20,181,000 (40.17%) | -$33,729,000 (-197.93%) |
Enterprise Value (EV) | -$44,837,025 (-745.96%) | -$5,300,146 (94.91%) | -$104,200,190 (-164.52%) | $161,502,453 |
Earnings Before Tax (EBT) | -$61,118,000 (20.03%) | -$76,422,000 (-8874.05%) | $871,000 (101.71%) | -$50,893,000 (-188.98%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$53,822,000 (22.71%) | -$69,637,000 (-1183.17%) | $6,429,000 (113.60%) | -$47,285,000 (-242.57%) |
Invested Capital | $22,330,000 (-37.06%) | $35,477,000 (11.31%) | $31,873,000 (70.76%) | $18,665,000 (-59.53%) |
Working Capital | $110,085,000 (-23.71%) | $144,307,000 (-28.13%) | $200,799,000 (-6.87%) | $215,607,000 (435.54%) |
Tangible Asset Value | $138,380,000 (-21.90%) | $177,189,000 (-22.87%) | $229,727,000 (-2.93%) | $236,655,000 (367.09%) |
Market Capitalization | $48,595,975 (-65.85%) | $142,305,854 (62.36%) | $87,646,810 (-77.36%) | $387,210,453 |
Average Equity | $137,345,250 (-26.47%) | $186,784,000 (-24.86%) | $248,567,750 (43.81%) | $172,849,750 (682.39%) |
Average Assets | $167,417,500 (-21.95%) | $214,506,000 (-23.18%) | $279,216,250 (15.90%) | $240,903,750 (591.17%) |
Invested Capital Average | $28,057,000 (-20.91%) | $35,477,000 (2.10%) | $34,748,000 (148.39%) | $13,989,250 (-43.77%) |
Shares | 40,228,456 (4.31%) | 38,565,272 (3.40%) | 37,296,515 (7.01%) | 34,852,426 (2.31%) |
